The acquisition will help Zydus expand its animal health business in India
Zydus Group, through its division Zydus Animal Health, has announced the strategic acquisition of select brands and the manufacturing operations of Zoetis, a global animal health company. The acquisition will help Zydus expand its animal health business in India and gain access to manufacturing operations which have also been catering to global markets. The financial details of the deal remain undisclosed.
As a result of this acquisition, Zydus gains access to a wide range of nutrition as well as therapeutic products which have strong brand equity and a combined turnover of Rs 171 crore. A major boost to Zydus‟ portfolio would be the addition of livestock farmcare products which are well accepted in the market. Zydus‟ access to the WHO GMP approved manufacturing facility is expected to boost its exports and institutional business. The plant spread over 10,000 sq metres manufactures tablets, liquid orals and injectables.
EP News Bureau – Mumbai